Covered recipient · General Payments record
JOSHUA WILSON
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$4,318.94
- Reported across 207 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $359.18 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $173.54 | 16 |
| Celgene Corporation | $47.61 | 3 |
| IRONWOOD PHARMACEUTICALS, INC | $31.81 | 2 |
| Madrigal Pharmaceuticals | $19.37 | 1 |
| PFIZER INC. | $19.17 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.79 | 1 |
| Lilly USA, LLC | $17.88 | 1 |
| GENZYME CORPORATION | $16.36 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $14.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.03 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345578 | CMS |
| ABBVIE INC. | $19.75 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345580 | CMS |
| ABBVIE INC. | $7.87 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345582 | CMS |
| ABBVIE INC. | $9.07 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345584 | CMS |
| ABBVIE INC. | $1.43 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345586 | CMS |
| ABBVIE INC. | $3.76 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345588 | CMS |
| ABBVIE INC. | $1.66 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345590 | CMS |
| ABBVIE INC. | $18.54 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345592 | CMS |
| ABBVIE INC. | $18.24 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345594 | CMS |
| ABBVIE INC. | $27.83 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345596 | CMS |
| ABBVIE INC. | $2.73 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345598 | CMS |
| ABBVIE INC. | $6.37 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345600 | CMS |
| ABBVIE INC. | $18.03 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345602 | CMS |
| ABBVIE INC. | $24.03 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345604 | CMS |
| ABBVIE INC. | $4.43 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345606 | CMS |
| ABBVIE INC. | $0.77 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106345608 | CMS |
| Celgene Corporation | $13.91 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101085297 | CMS |
| Celgene Corporation | $14.70 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101085303 | CMS |
| Celgene Corporation | $19.00 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101085319 | CMS |
| GENZYME CORPORATION | $16.36 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139827458 | CMS |
| Intercept Pharmaceuticals, Inc. | $14.65 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113636082 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $15.27 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153725367 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $16.54 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153725363 | CMS |
| Lilly USA, LLC | $17.88 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135088599 | CMS |
| Madrigal Pharmaceuticals | $19.37 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144185525 | CMS |
| PFIZER INC. | $19.17 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131315358 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.79 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137698302 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.